Karen P. Flores Rosario

Journal article JACC Adv · June 2026 Genetic testing is increasingly common for people with cardiomyopathies and arrhythmias, with cascade screening recommended for first-degree relatives of those carrying pathogenic or likely pathogenic variants. Consequently, a growing number of women of ch ... Full text Link to item Cite

From Zero to Zero Sum: Heart Offers in the Donation After Circulatory Death Era.

Journal article JACC Heart Fail · March 2026 Full text Link to item Cite

Listing patterns at the highest volume heart transplant centers: Multiple roads to transplant.

Journal article JHLT Open · February 2026 The current heart transplantation (HT) allocation system added additional progressive statuses to differentiate the highest risk patients and decrease waitlist mortality. We analyzed United Network for Organ Sharing thoracic organ data (10/18/2018-6/30/202 ... Full text Link to item Cite

View All Scholarly Works

Recent Grants

A Phase 2, adaptive, double-blinded, placebo-controlled, randomized, multi-center trial to evaluate the efficacy, safety and tolerability of intracoronary infusion of AB-1002 in adult subjects with New York Heart Association (NYHA) Class III

Clinical TrialPrincipal Investigator · Awarded by AskBio · 2025 - 2030

A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy

Clinical TrialCo Investigator · Awarded by Kardigan Inc. · 2026 - 2030

Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants with Heart Failure with Preserved Ejection Fraction and Left Ventricular Hypertrophy

Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2026 - 2029

View All Grants

Education

University of Wisconsin, School of Medicine and Public Health · 2017 M.D.